INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
申请人:Actelion Pharmaceuticals Ltd.
公开号:EP2931717B1
公开(公告)日:2016-12-07
US9718774B2
申请人:——
公开号:US9718774B2
公开(公告)日:2017-08-01
[EN] INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS D'INDOLE CARBOXAMIDE UTILISÉS EN TANT QU'ANTAGONISTES DU RÉCEPTEUR P2X7
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2014091415A1
公开(公告)日:2014-06-19
The invention relates to indole carboxamide derivatives of formula (I), (I) wherein R1, R 2, R 3, R 4, R5 and R6 are as defined in the description, their preparation and their use as pharmaceutically active compounds.
INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONIST
申请人:ACTELION PHARMACEUTICALS LTD
公开号:US20150322008A1
公开(公告)日:2015-11-12
The invention relates to indole carboxamide derivatives of formula (I),
wherein R
1
, R
2
, R
3
, R
4
, R
5
and R
6
are as defined in the description, their preparation and their use as pharmaceutically active compounds.